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Cardiac Effects of Carbon Dioxide-Consuming and Carbon
Dioxide-Generating Buffers During Cardiopulmonary Resuscitation
RAUL J. GAZMURI, MD, MARTIN VON PLANTA, MD, MAX HARRY WElL, MD, PHD, FACC,
ERIC C. RACKOW, MD, FACC
North Chicago, Illinois
Recent studies have demonstrated an increase in carbon
dioxide (C02) tension (Peo2) in both mixed venous and
coronary vein blood early in the course of cardiac arrest
and cardiopulmonary resuscitation. Because increased Peo2
in the myocardium correlates with both ischemic injury and
depression of contractile function, the effects of hypertonic
solutions of either the CO2-''generating'' sodium bicarbon-
ate (NaHC03) buffer, a mixture of sodium carbonate
(Na2C03) and sodium bicarbonate (carbicarb) acting as a
CO2-''consuming'' buffer, or saline placebo (NaCl) were
compared during cardiopulmonary resuscitation in 25
healthy minipigs.
Both buffer agents significantly increased the pH and
HC03- of arterial, mixed venous and coronary vein blood.
Bicarbonate increased whereas carbicarb reduced blood
Soon after modern cardiopulmonary resuscitation was intro-
duced into clinical practice (1), the administration of sodium
bicarbonate was recommended as a routine for correction of
metabolic acidosis (2,3). However, studies by Bishop and
Weisfeldt (4) in dogs and by Weil et al. (5) in humans
demonstrated that the pH of arterial blood during the initial
20 min of cardiac arrest was more often maintained in the
normal range by a proportional decline in carbon dioxide
tension (Pco2) and HC03-. Studies (5,6) in a porcine model
of cardiac arrest and in human patients demonstrated strik-
ing acidemia in blood sampled from the right side of the
heart. However, this venous acidemia was selectively due to
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Peo2 in the systemic circuit as anticipated. However, nei-
ther the Peo2 nor the lactate content of coronary vein blood
was favorably altered by buffer therapy. Four of eight
animals treated with bicarbonate, five of eight treated with
carbicarb and six of nine placebo-treated animals were
successfully resuscitated and had a comparable 24 h sur-
vival rate. Coronary perfusion pressure during precordial
compression, a critical determinant of resuscitability, was
transiently decreased by each of the hypertonic solutions.
Accordingly, neither CO2-generating nor CO2-consum-
ing buffers mitigated increases in coronary vein Peo2 or
improved the outcome of cardiopulmonary resuscitation
under these experimental conditions.
(J Am Coll CardioI1990;15:482-90)
increases in Pc02 rather than to decreases in plasma bicar-
bonate. We subsequently demonstrated (7) a striking reduc-
tion in coronary vein blood pH to levels of approximately
6.9, accompanied by an increase in Pco2 to average levels of
125 mm Hg during porcine cardiopulmonary resuscitation.
These acid-base defects were observed within the initial 5
min after onset of cardiac arrest, at the time when aortic
blood pH and Pco2 were within normal range. Accordingly,
buffer therapy early in the course of cardiopulmonary resus-
citation is primarily intended to neutralize the effects of
acidosis in the coronary circuit and myocardium rather than
to act in the systemic circuit.
Accumulation of COz within the myocardium has been
implicated as a cause of decreased myocardial contractility
(8-10). Because sodium bicarbonate increases pH but gen-
erates COz (11), we reasoned that this buffer agent may
decrease resuscitability by augmenting hypercarbia. We
therefore sought a buffer agent that would increase pH in the
coronary circulation without the potential adverse effect of
increased Pco2.
In earlier studies (12) with tromethamine, an organic
CO2-consuming buffer, we observed a reduction in venous
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hypercapnia during porcine cardiopulmonary resuscitation.
However, this buffer induced arterial vasodilation, by which
it decreased aortic diastolic pressure and critically reduced
coronary perfusion pressure during precordial compression.
These effects accounted for the decrease in resuscitability
when compared with sodium bicarbonate. We therefore
sought an alternative COz-consuming buffer. Because so-
dium carbonate (NazC03) consumes COz and generates
HC03-, it potentially fulfills these requirements. However,
the marked alkalinity of a hypertonic solution of sodium
carbonate (pH>11) would be likely to preclude routine
administration in human patients. This disadvantage was
overcome with the introduction of an equimolar mixture of
sodium carbonate and sodium bicarbonate (carbicarb) (13).
Recently, in a canine model of hypoxic lactic acidosis,
Bersin and Arieff (14) observed depression of cardiac func-
tion and an increase in arterial blood lactate after infusion of
sodium bicarbonate. Conversely, when carbicarb was in-
fused, there were no detrimental effects on cardiac function
and the increase in arterial lactate concentrations was min-
imal.
In the present study, we investigated the effects of
bicarbonate as a COz-"generating" and that of carbicarb as
a COz-"consuming" buffer and compared these with a
sodium equivalent "control" solution of hypertonic sodium
chloride. Our model was selected to simulate a typical
clinical event of "sudden death" in which resuscitation,
including positive pressure ventilation with 100% oxygen
and precordial compression, is initiated after 5 min and
defibrillation within 13 min (15-17).
Methods
Animal preparation. The animal care and experimental
procedures were in accord with the guidelines stated in the
Guidefor the Care and Use ofLaboratory Animals. Twenty-
five miniature pigs (Minnesota minipigs) ranging from 4to 13
months in age and weighing between 22 and 32 kg were
sedated by intramuscular injection of ketamine (20 mg/kg).
Anesthesia was induced by ear vein injection of sodium
pentobarbital (15 mg/kg). A cuffed endotracheal tube was
advanced into the trachea, and the animals were ventilated
throughout the entire procedure with the aid of a volume-
controlled ventilator (model MA-l, Puritan Bennett) at a
frequency of 12 breaths/min, tidal volume of 12 cc/kg, peak
flow of 40 liters/min and concentration of inspired oxygen in
air (FiOz) of 0.5. During animal preparation and before
cardiac arrest, minute ventilation was adjusted to maintain
Pacoz between 35 and 45 mm Hg. No further changes were
made during or after cardiac arrest. Supplemental intrave-
nous injections of pentobarbital (5 mglkg) were administered
at intervals of approximately 45 min to maintain anesthesia.
A7F pentalumen thermodilution catheter (model SP5527,
Gould Inc.) was advanced into a surgically exposed femoral
vein and flow directed into the pulmonary artery with
oscillographic monitoring. Through the right femoral artery,
an 8F angiographic catheter (model 6523, USCI C.R. Bart
Inc.) was advanced into the thoracic aorta. Through the
surgically exposed left cephalic vein, a 7F angiographic
catheter (model 5470, USCI C.R. Bart Inc.) was advanced
into the superior vena cava and, with the aid of an image
intensifier, advanced into the right atrium and the coronary
sinus. It was then looped laterally and advanced inferiorly
for a distance of 3 to 6 cm into the great cardiac vein
(coronary vein). Through the right cephalic vein, a 5F
balloon-tipped pacing catheter (model 97-120-5F, American
Edwards) was advanced with electrocardiographic monitor-
ing until a current of injury was recorded from the endocar-
dium of the right ventricle. Correct catheter position was
confirmed fluoroscopically and subsequently at autopsy in
nonresuscitated animals. Patency of the catheters was main-
tained with continuous infusion of physiologic salt solution
containing 10 units/ml of bovine heparin at a rate of 3 ml/h,
with interposed manual flushes to deliver approximately 15
ml/h. In addition, physiologic salt solution was continuously
infused in amounts of 5 ml/kg per h throughout the experi-
ment. Blood temperature was measured in the pulmonary
artery and maintained between 37° and 38°C by external
infrared lamps.
Measurements. Arterial, pulmonary artery (mixed ve-
nous) and coronary vein blood gases were measured with the
aid of an automated pH/blood gas analyzer (model 813,
Instrumentation Laboratory Inc.) and lactate with an elec-
trode-based lactate analyzer (model 23L, YeHow Springs
Instrument Co.) previously validated for porcine blood (18).
To assess the osmolal effects of the buffers, serum osmolal-
ity was measured by the freezing point depression technique
with a Digimatic osometer (model 3DII, Advanced Instru-
ments Inc.) by techniques previously described (19).
Aortic, pulmonary artery and right atrial pressures were
measured through fluid-filled catheters with the aid of strain
gauge pressure transducers (model P50 or P23Db, Gould
Inc.). Coronary perfusion pressure was estimated as the
arithmetic difference between time-coincident aortic and
right atrial diastolic pressure. Cardiac output was measured
by thermodilution technique with the aid of a cardiac output
computer (model 9520, American Edwards Laboratories)
after bolus injection of 5 ml of 5% glucose at a temperature
between 0° to 4°C into the right atrium.
The volume of expired air was measured throughout the
procedure with a Fleisch pneumotachometer (model 7319,
Dynasciences Corp.). Through a side wall manifold adapted
to the endotracheal tube, gas in the airway was continuously
sampled at a rate of 200 ml/min. The COz concentration of
this gas was measured with an infrared COz analyzer (model
200, Instrumentation Laboratory Inc.) by techniques previ.
ously described (20).
Dynamic data including the electrocardiogram (lead 11),
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Adapted from Filley et al. (13), with permission.
Table 1. Composition and Physical Characteristics of Buffer
Agents and Placebo
vascular pressures and expiratory gas volume and COz
concentration were continuously recorded with the aid of an
eight channel direct thermal recorder (model 7758A, Hewlett
Packard).
Experimental procedure. Ventricular fibrillation was in-
duced by 10 mA of alternating current delivered to the right
ventricular endocardium, after which the inspired concen-
tration of oxygen was increased from 0.5 to 1. After 5 min of
untreated ventricular fibrillation, precordial compression
was begun with the aid of a pneumatic piston device
(Thumper, model 1000, Michigan Instrument) at a rate of
6O/min and synchronized to ventilation with a ratio of 5: 1.
The compression pad was centered at the junction of the
middle and lower third of the sternum. It was programmed to
provide equal compression/relaxation intervals (that is, 50%
duty cycle). The compression force was adjusted to decrease
the anteroposterior diameter by 25% to 30%.
The test drugs were supplied and coded by International
Medication Systems Ltd. The investigators did not know
which drugs they were using and the code was broken only
after the study was completed. The composition and con-
centration of the test drugs are summarized in Table 1. A
dose of 2.5 ml/kg of solution was infused through the right
atrial port of the pulmonary artery catheter over an interval
of 2 min, beginning 8 min after the onset of ventricular
fibrillation and 3 min after the start of precordial compres-
sion.
After 13 min of ventricular fibrillation (8 min after the
start ofprecordial compression), a maximum of three 300 J
direct current countershocks was delivered between the
right infraclavicular area and the cardiac apex. Failing to
reverse ventricular fibrillation, the countershocks were re-
peated after a 30 s period of chest compression. This
resuscitation protocol was repeated for a maximum of three
times. Aortic, mixed venous and coronary vein blood mea-
surements were obtained 2 min before and at 7 and 11 min
after the onset of ventricular fibrillation. In successfully
resuscitated animals, the measurements were repeated at 2,
30 and 60 min after the return of spontaneous circulation; all
catheters were removed after the measurements at 60 min.
Sodium Sodium Carbonate + Sodium
Bicarbonate Sodium Bicarbonate Chloride
Results
Atotal of25 studies were completed. Sodium bicarbonate
and carbicarb were administered to eight pigs each and
sodium chloride placebo to nine. The weight and gender
were comparable for each group of animals. There were no
differences in hemodynamic or acid-base variables before
induction of cardiac arrest among the three groups.
Hemodynamic and acid-base changes associated with car-
diac arrest. Cardiac arrest was confirmed in all animals by
an abrupt decrease in mean aortic pressure from 142 ± 4 to
18 ± 1 mm Hg and a sharp decline in end-tidal Pcoz from
31 ± I to 2 ± 0 mm Hg after 4 min of untreated ventricular
fibrillation. After precordial compression was begun, mean
aortic pressure increased to 48 ± 3 mm Hg and end-tidal
Peoz to 14 ± I mm Hg. A representative record that
demonstrates these changes is shown in Figure I. The
coronary perfusion pressure, which was 129 ± 3 mm Hg
before cardiac arrest, decreased to 3 ± I mm Hg during
cardiac arrest. During precordial compression and before
drug infusion, coronary perfusion pressure was increased to
17 ± 2 mm Hg.
The results of arterial, mixed venous and coronary vein
blood gas measurements are summarized in Table 2. After
the onset of cardiac arrest, the changes were like those
previously reported by us (5-7). Cardiopulmonary resusci-
tation was not initially accompanied by arterial acidemia.
Because Peoz and HC03- were proportionally decreased in
aortic blood, the aortic blood pH remained at approximately
prearrest levels. Selective increases in Pcozin mixed venous
blood accounted for sharp increases in the venoarterial
gradients for both Peoz and pH. Minor increases in lactic
acid concentrations were observed in both aortic and mixed
venous blood. As previously reported (7), Pcoz and lactate
content of coronary vein blood were strikingly increased and
coronary vein pH was, therefore, markedly reduced.
Osmolal, hemodynamic and acid-base changes after buffer
agent. The plasma osmolality was essentially the same in
blood sampled from the aorta, pulmonary artery and coro-
After awakening with return of the cough reflex, the animals
were extubated and observed for an additional 24 h. Respon-
siveness was scored at the end of that interval as fully active,
decreased spontaneous activity, impaired responsiveness or
coma. Autopsy was performed in all animals, and intraab-
dominal and intrathoracic organs were grossly inspected.
Statistical analysis. Data are reported as mean values ±
SEM. Categorical outcomes were compared by Fisher's
exact test. Changes after buffer infusion and after resuscita-
tion were analyzed by two-tailed t test for paired data.
Differences among groups were analyzed by one-way anal-
ysis of variance and the Scheffe multiple comparison proce-
dure. A stepwise discriminant function was utilized to iden-
tify variables that correlated with cardiac resuscitability.
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Figure 1. Representative experimental
recording. Induction of ventricular fi-
brillation (VF) is followed by an abrupt
decrease in aortic pressure and end-
tidal CO2 (ETC02). Precordial compres-
sion is begun after 5 min of ventricular
fibrillation, which generates aortic, pul-
monary artery (P. ART) and right (R.)
atrial pulse pressure and increases end-
tidal CO2, After 13 min of ventricular
fibrillation, electrical defibrillation (DF)
is followed by restoration of spontane-
ous circulation accompanied by promi-
nent increases in end-tidal CO2, EKG =
electrocardiogram; VOL = volume.
,
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nary vein. It was transiently increased from 299 ± 2to 374 ±
6 mOsmlliter (p < 0.001) and approximately equal increases
were observed in the three groups (Fig. 2). As anticipated,
end-tidal Pco2 increased after CO2-generating bicarbonate,
decreased after administration of CO2-consuming carbicarb
and there were no changes after sodium chloride infusion
(Fig. 3). During infusion of each of the hypertonic solutions
and independently of acid-base changes, there was a de-
crease in aortic diastolic pressure from 24 ± 2 to 19 ± 2 mm
Hg (p < 0.001, n = 24) and an increase in right atrial pressure
from 9 ± 1 to 11 ± 1 mm Hg (p = 0.001. Consequently, the
coronary perfusion pressure decreased from 17 ± 2 to 8 ± 2
mm Hg (p < 0.001) without significant differences between
bicarbonate, carbicarb or saline control infusions (Fig. 4).
This effect was transient and most prominent during the 2
min interval of buffer and saline infusion. Three minutes
after completion of infusion, coronary perfusion pressure
had increased to 11 ± 2 mm Hg (p = 0.001).
Both bicarbonate and carbicarb significantly increased
pH and HC03 - in arterial, mixed venous and coronary vein
blood. Bicarbonate increased, whereas carbicarb decreased
Pco2 in arterial and mixed venous blood (Table 2). In the
saline placebo-treated group, pH and HC03- were mini-
mally altered. A numeric but not statistically significant
reduction in PC02 of coronary vein blood was detected after
bicarbonate, carbicarb and saline placebo infusion. A mild
increase in arterial and mixed venous lactate concentration
was time-coincident with a marked increase in coronary vein
lactate. This indicated significant myocardial lactate produc-
tion. Whereas the buffer agents increased coronary vein pH
and decreased the coronary venoarterial H+ gradients, nei-
ther CO2 nor lactate production was favorably altered
(Fig. 5).
Resuscitation. External countershock resulted in rever-
sion of ventricular fibrillation in each instance. However,
spontaneous circulation was sustained in only four of eight
pigs treated with bicarbonate, five of eight treated with
carbicarb and six of nine treated with sodium chloride. In
each of the other 10 animals, electromechanical dissociation
was documented after completion of the resuscitation pro-
tocol. In resuscitated animals, there was moderate depres-
sion of cardiac function, which persisted for ~60 min after
restoration of spontaneous circulation. This was docu-
mented by a decrease in cardiac index from 127 ± 8 ml/kg
per min before cardiac arrest to 79 ± 9 ml/kg per min at 60
min after resuscitation (p < 0.001), a decrease in mean aortic
pressure from 141 ± 5 to 105 ± 7 mm Hg (p < 0.001) and
increase in mean pulmonary wedge pressure from 4 ± 1 to
7 ± 1 mm Hg (p < 0.05) without significant differences
among the three groups. At 24 h, four pigs treated with
bicarbonate, four treated with carbicarb and six in the
placebo-treated group were alive. Each of the survivors was
fully responsive except for one saline-treated animal. This
animal had decreased spontaneous activity, but was respon-
sive to auditory and tactile stimuli. Accordingly, no statisti-
cally significant difference in initial resuscitability, hemody-
namic recovery, 24 h survival or behavioral responsiveness
was observed among the three treatment groups.
When resuscitated and nonresuscitated pigs were statis-
tically compared independently of buffer treatment by dis-
criminant function analysis, coronary perfusion pressure
generated during cardiopulmonary resuscitation emerged as
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Table 2. Aortic, Mixed Venous and Coronary Venous pH, PC02' HC03- and Lactate Before and After Administration of Buffers and
NaCI in 25 Pigs
Control Before After Resuscitation
No. -2 min 7 min II min Value No. +2 min +30 min
pHao (units)
Sodium bicarbonate 8 7.49 ± 0.02 7.53 ± 0.05 7.85 ± 0.08 <0.001 4 7.33 ± 0.04 7.40 ± 0.02
Carbicarb 8 7.49 ± 0.01 7.58 ± 0.06 8.21 ± 0.14 <0.001 5 7.32 ± 0.01 7.37 ± 0.02
Sodium chloride 9 7.46 ± 0.01 7.50 ± 0.04 7.41 ± 0.04 0.014 6 7.13 ± 0.00 7.29 ± 0.03
pHv (units)
Sodium bicarbonate 8 7.42 ± 0.01 7.33 ± 0.03 7.48 ± 0.03 <0.001 4 7.29 ± 0.04 7.32 ± 0.02
Carbicarb 8 7.45 ± 0.02 7.32 ± 0.Q3 7.73 ± 0.06 <0.001 5 7.25 ± 0.2 7.29 ± 0.02
Sodium chloride 9 7.44 ± 0.01 7.28 ± 0.03 (8) 7.22 ± 0.03 (8) 0.002 6 7.09 ± 0.04 7.22 ± 0.04
pHcv (units)
Sodium bicarbonate 8 7.41 ± 0.02 6.81 ± 0.09 (6) 7.31 ± 0.07 (7) <0.001 4 7.31 ± 0.04 7.33 ± 0.02
Carbicarb 8 7.42 ± 0.01 6.74 ± 0.11 (7) 7.25 ± 0.14 (7) 0.002 5 7.28 ± 0.02 7.30 ± 0.03
Sodium chloride 9 7.40 ± 0.01 6.67 ± 0.08 6.73 ± 0.07 (7) NS 6 7.09 ± 0.04 7.23 ± 0.02
PaoC02(mm Hg)
Sodium bicarbonate 8 38 ± 1 28 ± 3 40 ± 5 0.002 4 64 ± 3 47 ± 3
Carbicarb 8 38 ± I 24 ± 3 18 ± 4 0.001 5 60 ± 3 43 ± 2
Sodium chloride 9 40 ± 1 29 ± 4 30 ± 4 NS 6 62 ± 7 39 ± 4
PvC02 (mm Hg)
Sodium bicarbonate 8 46 ± 1 58 ± 5 85 ± 8 0.008 4 75 ± 5 64 ± 2
Carbicarb 8 46 ± I 58 ± 5 40 ± 3 0.004 5 76 ± 4 61 ± 2
Sodium chloride 9 47 ± 1 61 ± 8 (8) 61 ± 4 (8) NS 6 77 ± 6 56 ± 3
PcvC02 (mm Hg)
Sodium bicarbonate 8 52 ± 1 144 ± 18 (6) 126 ± 17 (7) NS 4 70 ± 5 63 ± 3
Carbicarb 8 52 ± 2 162 ± 28 (7) 119 ± 31 (7) NS 5 69 ± 6 61 ± 4
Sodium chloride 9 52 ± 2 182 ± 22 151 ± 49 (7) NS 6 71 ± 8 57 ± 4
HC03-ao (mmolJliter)
Sodium bicarbonate 8 28 ± I 22 ± 1 65 ± 5 <0.001 4 32 ± 2 27 ± I
Carbicarb 8 28 ± I 20 ± I 62 ± 8 0.001 5 29 ± 2 24 ± 0
Sodium chloride 9 27 ± I 20 ± 1 17 ± I 0.003 6 19 ± I 18 ± I
HC03- v (mmoVliter)
Sodium bicarbonate 8 30 ± I 28 ± I 59 ± 4 <0.001 4 34 ± 2 31 ± I
Carbicarb 8 30 ± I 27 ± I 50 ± 5 0.002 5 31 ± I 28 ± 0
Sodium chloride 9 29 ± I 27 ± 1(8) 23 ± 1(8) 0.001 6 22 ± I 22 ± I
HC03-cv (mmolJliter)
Sodium bicarbonate 8 32 ± I 21 ± 2 (6) 58 ± 4 (7) <0.001 4 33 ± 2 31 ± I
Carbicarb 8 31 ± I 20±2(7) 44±5(7) 0.001 5 30 ± I 28 ± 0
Sodium chloride 9 31 ± I 19 ± 1 18 ± 1(7) NS 6 20 ± I 23 ± I
Lao (mmoVliter)
Sodium bicarbonate 8 1.0 ± 0.1 2.4 ± 0.2 3.9 ± 0.3 <0.001 4 5.3 ± 0.7 3.4 ± 0.2
Carbicarb 8 1.0 ± 0.1 2.6 ± 0.4 4.4 ± 0.4 <0.001 5 7.5 ± 0.7 4.6 ± 0.2
Sodium chloride 9 1.0 ± 0.1 2.7 ± 0.3 3.8 ± 0.4 <0.001 6 5.9 ± 0.4 4.1 ± 0.3
Lv (mmolJliter)
Sodium bicarbonate 8 0.9 ± 0.1 2.6 ± 0.3 4.0 ± 0.4 <0.001 4 5.2 ± 0.7 3.1 ± 0.2
Carbicarb 8 0.9 ± 0.1 2.9 ± 0.3 4.7 ± 0.4 <0.001 5 7.3 ± 0.7 4.3 ± 0.3
Sodium chloride 9 1.0 ± 0.1 3.0 ± 0.4 (8) 3.9 ± 0.4 (8) <0.001 6 5.7 ± 0.4 3.9 ± 0.4
Lcv (mmoVliter)
Sodium bicarbonate 8 0.5 ± 0.1 6.7 ± 1.1 (5) 7.7 ± 1.6 (7) NS 4 5.2 ± 0.8 2.7 ± 0.1
Carbicarb 8 0.4 ± 0.1 9.0 ± I.2 (7)' 12.5 ± 1.8 (7) 0.037 5 8.1 ± 1.1 3.9 ± 0.3
Sodium chloride 9 0.6 ± 0.1 8.3 ± 1.1 8.8 ± 1.1 (7) 0.025 6 6.5 ± 0.5 3.7 ± 0.4
Ventricular fibrillation was induced at 0 time; precordial compression was begun at 5 min. Data are reported as mean ± standard error of the mean. The
number of observations when <9 measurements for sodium chloride or <8 for each buffer group is shown in parentheses. Ao = aortic; cv = coronary venous;
L = lactate; p = paired t test 7 vs. II min; v= mixed venous.
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Figure 2. Plasma osmolality. A transient increase in osmolality is
measured in plasma from arterial blood after infusion of hypertonic
buffers and hypertonic sodium chloride (saline) in 25 pigs. p = NS
for saline versus carbicarb versus bicarbonate.
the single most important indicator of cardiac resuscitability
(p < 0,001). When the effects of coronary perfusion pressure
were excluded from the discriminant function model, neither
the acid-base defects in arterial or mixed venous nor those of
coronary vein blood predicted either cardiac resuscitability
or 24 h survival. Moreover, when coronary perfusion pres-
sure was 2: 10 mm Hg after drug administration and before
defibrillation, each of 13 pigs was successfully resuscitated.
When coronary perfusion pressure immediately before at-
tempted defibrillation was <10 mm Hg, however, only 2 of
12 pigs could be successfully resuscitated (p < 0.001). The
threshold of 10 mm Hg, representing a critical coronary
perfusion pressure value for myocardial resuscitability, ap-
plied to each of the three treatment groups (Fig. 6).
-2 0 +30 +60 Figure 4. Effect of sodium bicarbonate, carbicarb and hypertonic
saline solution on coronary perfusion pressure during precordial
compression. Bicarb = bicarbonate; Carbic = carbicarb.
Autopsy findings. No major injuries to internal organs
were detected. Minimal hemorrhagic lesions in the lungs
developed in all animals. These were related to traumatic
injuries of the anterior chest wall and especially rib fractures
after precordial compression.
Discussion
Acid-base changes during cardiac arrest. During human
and experimental cardiopulmonary resuscitation we have
previously demonstrated (5,21) an early increase in mixed
venous Pco2 with a concurrent decrease in arterial Pco2. This
acid-base defect occurred in the absence of clinically rele-
vant systemic lactic acidosis, but in close relation with a
marked decrease in CO2 elimination through the lungs as a
result of a decrease in pulmonary blood flow (20,22,23). In
coronary vein blood, however, a striking increase in both
Figure 3. Representative cases illustrating the
effects of sodium bicarbonate, carbicarb and
saline placebo on end-tidal CO2, RESUSC. =
resuscitation; other abbreviations as in Figure
1.
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CO2 (36-39). Because CO2 is highly diffusible across cell
membranes, it rapidly equilibrates between the intracellular
and extracellular fluid compartments of the heart and also
with coronary vein blood (40-42). The observed increase in
coronary vein PC02 is, therefore, consistent with global
myocardial ischemia.
Treatment with buffer agents. Routine bicarbonate ad-
ministration has been advocated during cardiopulmonary
resuscitation on the assumption that it will neutralize the
detrimental effects of metabolic (lactic) acidosis (2,3). Be-
cause bicarbonate dissociates into CO2 and H20, it poten-
tially increases CO2, Rapid diffusion of the CO2 across cell
membranes contrasts with delayed diffusion of HC03-. This
explains the remarkably rapid decrease in intracellular pH
(30,31). In 1910, the famed English physiologist Starling and
his coworker Jerusalem (43) first demonstrated that perfu-
sion of isolated frog ventricle with salt solution equilibrated
with 16% CO2 (about 120 mm Hg) depressed myocardial
contractility by 80%. Poole-Wilson and Langer (44) also
demonstrated that respiratory acidosis was more detrimental
than metabolit acidosis to myocardial contractility despite a
comparable reduction in extracellular pH. When sodium
bicarbonate was injected into the coronary arteries or into
the left atrium, myocardial contractility was transiently
decreased (45,46). Because of the increased CO2 load,
administration of sodium bicarbonate is likely to decrease
myocardial cell pH despite an increase in coronary pH.
Studies in our own laboratory (47) using an isolated
(Langendorfl) rat heart preparation recently confirmed a
striking reduction in myocardial contractility when the heart
was perfused with Krebs-Henseleit solution equilibrated
with Pco2 ranging from 36 to 156 mm Hg. We therefore
looked to buffer agents that would consume rather than
generate COz as more optimal for reversing myocardial
acidosis. In selecting carbicarb buffer, we anticipated and
found that carbonate ion (C03-) binds H+, consumes COz
and generates HC03- according to the following reaction:
We observed that both buffers increased systemic and
coronary pH and HC03- to the extent that marked systemic
alkalemia coexisted with partial correction of coronary vein
pH. However, neither the COz-generating nor the COz-
consuming effects of the buffers altered the PC02 tension in
coronary vein blood. This differed from our prior observa-
tion (12) under comparable experimental conditions with the
organic CO2-consuming buffer tromethamine, which pro-
duced highly significant reductions in coronary vein COz in a
larger number of animals. The predominant effect of both
bicarbonate and carbicarb was to increase HC03- and pH in
both the systemic and the coronary circuit without a signif-
icant change in myocardial COz production. Accordingly,
failure to demonstrate either benefit or detriment of buffer
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Figure 5. Coronary venoarterial gradients of H+, Pe02, HC03- and
lactate. There were no significant differences among the effects of
the three agents on Peo2' HC03- and lactate. However, both buffers
significantly reduced H+ gradients in comparison with sodium
chloride. *p = 0.05 for bicarbonate and carbicarb.
Figure 6. Coronary perfusion pressure (in mm Hg) 13 min after onset
of ventricular fibrillation (8 min after the start of precordial com-
pression). *p < 0.05; **p < 0.01. Abbreviations as in Figure 3.
Pco~ and lactate accounted for a marked decrease in coro-
nary venous pH (7). This is best explained by global myo-
cardial ischemia with accumulation of metabolic byproducts
of anaerobic metabolism in the myocardium and coronary
circulation.
During ventricularfibrillation, the oxygen demands ofthe
heart are not reduced, but may actually increase (24-26).
Because myocardial blood flow during precordial compres-
sion rarely exceeds 40% of normal, myocardial oxygen
stores are rapidly exhausted and mitochondrial adenosine
triphosphate (ATP) production is critically curtailed (27,28).
Even though anaerobic glycolysis provides fuel for regener-
ation of high energy phosphate, it does not meet the meta-
bolic demands of the heart. After 20 min of ischemia, there
is almost complete depletion of creatine phosphate, a very
marked reduction of ATP and a proportional decrease in
myocardial contractility. Excesses of H+ also inhibit the
influx of calcium such that contractile function is dispropor-
tionately reduced. Irreversible loss of cardiac function oc-
curs after exhaustion of ATP stores (29-35).
The excess ofH+ generated during ischemia, buffered by
the bicarbonate system, would account for accumulation of
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therapy in relation to immediate resuscitability or 24 h
survival does not invalidate the concept that increases in
myocardial H+ concentration and CO2 tension may account
for early loss of myocardial resuscitability. However, these
data fail to support the concept that buffering of excesses of
H+ alters outcome.
Coronary perfusion pressure. We further observed that
hemodynamic rather than metabolic variables predominate
as indicators of cardiac resuscitability. Coronary perfusion
pressure, which is a remarkably good estimate ofmyocardial
blood flow during cardiopulmonary resuscitation (48-50),
was again recognized as the single most important hemody-
namic determinant of myocardial resuscitability (51-53). A
decrease in aortic diastolic pressure and a concurrent in-
crease in right atrial pressure were observed during the
administration of hypertonic buffers or hypertonic saline
solution. This effect was attributed to a direct vasodilator
action of hyperosmolal solutions (54-56) in association with
expansion of the intravascular blood volume and, therefore,
augmented right atrial preload and pressure. Such effects,
which may be beneficial in the treatment of other low flow
states such as hypovolemic, septic and traumatic shock, are
likely to be detrimental in the setting of cardiopulmonary
resuscitation; a decrease in aortic diastolic pressure together
with an increase in right atrial pressure further reduced the
pressure gradient for myocardial perfusion independently of
any acid-base effect.
Conclusions. Hypertonic CO2-generating and CO2-con-
suming buffers during cardiopulmonary resuscitation re-
versed acidemia in both the systemic and the coronary
circuit; however, neither coronary vein Peo2 nor myocardial
resuscitability was significantly altered, Accordingly, the
routine use of either CO2-generating or COz-consuming
buffers for cardiopulmonary resuscitation is unsupported by
these experimental observations.
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